Microbiota regulates the TET1-mediated DNA hydroxymethylation program in innate lymphoid cell differentiation.
Xusheng ZhangXintong GaoZhen LiuFei ShaoDou YuMin ZhaoXiwen QinShuo WangPublished in: Nature communications (2024)
Innate lymphoid cell precursors (ILCPs) develop into distinct subsets of innate lymphoid cells (ILCs) with specific functions. The epigenetic program underlying the differentiation of ILCPs into ILC subsets remains poorly understood. Here, we reveal the genome-wide distribution and dynamics of the DNA methylation and hydroxymethylation in ILC subsets and their respective precursors. Additionally, we find that the DNA hydroxymethyltransferase TET1 suppresses ILC1 but not ILC2 or ILC3 differentiation. TET1 deficiency promotes ILC1 differentiation by inhibiting TGF-β signaling. Throughout ILCP differentiation at postnatal stage, gut microbiota contributes to the downregulation of TET1 level. Microbiota decreases the level of cholic acid in the gut, impairs TET1 expression and suppresses DNA hydroxymethylation, ultimately resulting in an expansion of ILC1s. In adult mice, TET1 suppresses the hyperactivation of ILC1s to maintain intestinal homeostasis. Our findings provide insights into the microbiota-mediated epigenetic programming of ILCs, which links microbiota-DNA methylation crosstalk to ILC differentiation.
Keyphrases
- dna methylation
- genome wide
- nk cells
- signaling pathway
- gene expression
- circulating tumor
- single molecule
- peripheral blood
- cell free
- quality improvement
- cell proliferation
- induced apoptosis
- stem cells
- poor prognosis
- single cell
- adipose tissue
- preterm infants
- type diabetes
- skeletal muscle
- copy number
- nucleic acid
- epithelial mesenchymal transition
- young adults
- mesenchymal stem cells
- cell cycle arrest
- endoplasmic reticulum stress
- cell death